Andales, Eliseo C.
HRN: 21-79-49 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/16/2022
08/23/2022
IV
1.5g
Q6
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes